Imaging Prostate Cancer

Radiologic Clinics of North America

Volumn 50, Issue 6, 2012, Pages 1043-1059

  Jung, Adam J ^a   Westphalen, Antonio C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diffusion weighted imaging; Dynamic contrast enhancement; Magnetic resonance imaging; Magnetic resonance spectroscopic imaging; Prostate cancer

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PROGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCINTISCANNING; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATE; PROSTATIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84868291161     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2012.08.001     Document Type: Review

References (56)

1. American Cancer Society Cancer facts and figures 2012 2012, American Cancer Society, Atlanta.
2. Chustecka Z. Recommendation against routine PSA screening in US. Medscape Urology News 2011, Available at:, Accessed August 27, 2012. http://www.medscape.com/viewarticle/751159.
3. Djavan B. Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials. Eur Urol 2011, 59(3):365-369. [editorial].
4. Myers R.P., Cheville J.C., Pawlina W. Making anatomic terminology of the prostate and contiguous structures clinically useful: historical review and suggestions for revision in the 21st century. Clin Anat 2010, 23(1):18-29.
5. McNeal J.E. Anatomy of the prostate: an historical survey of divergent views. Prostate 1980, 1(1):3-13.
6. Coakley F.V., Hricak H. Radiologic anatomy of the prostate gland: a clinical approach. Radiol Clin North Am 2000, 38(1):15-30.
7. Vo T., Rifkin M.D., Peters T.L. Should ultrasound criteria of the prostate be redefined to better evaluate when and where to biopsy. Ultrasound Q 2001, 17(3):171-176.
8. Ismail M., Gomella L.G. Ultrasound for prostate imaging and biopsy. Curr Opin Urol 2001, 11(5):471-477. [review].
9. Rabbani F., Stroumbakis N., Kava B.R., et al. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 1998, 159(4):1247-1250.
10. Kvale R., Moller B., Wahlqvist R., et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 2009, 103(12):1647-1654.
11. D'Amico A.V., Tempany C.M., Cormack R., et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000, 164(2):385-387.
12. Epstein J.I., Walsh P.C., Carmichael M., et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994, 271(5):368-374. [see comments].
13. Westphalen A.C., Koff W.J., Coakley F.V., et al. Prostate cancer: prediction of biochemical failure after external-beam radiation therapy-Kattan nomogram and endorectal MR imaging estimation of tumor volume. Radiology 2011, 261(2):477-486.
14. Wang L. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004, 232(1):133-139.
15. Qayyum A., Coakley F.V., Lu Y., et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004, 183(4):1079-1083.
16. Tamada T., Sone T., Jo Y., et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008, 248(2):531-539.
17. Hom J.J., Coakley F.V., Simko J.P., et al. Endorectal MR and MR spectroscopic imaging of prostate cancer: histopathological determinants of tumor visibility. AJR Am J Roentgenol 2005, 184(Suppl 4):S62.
18. Schiebler M.L., Schnall M.D., Outwater E. MR imaging of mucinous adenocarcinoma of the prostate. J Comput Assist Tomogr 1992, 16(3):493-494.
19. Westphalen A.C., Coakley F.V., Kurhanewicz J., et al. Mucinous adenocarcinoma of the prostate: MR imaging and MR spectroscopic imaging features. AJR 2009, 193(3):W238-W243.
20. Rosenkrantz A.B., Mannelli L., Kong X., et al. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization. JMRI 2011, 34(1):95-100.
21. Chen M., Hricak H., Kalbhen C.L., et al. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol 1996, 166(5):1157-1163.
22. Westphalen A.C., Kurhanewicz J., Cunha R.M., et al. T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol 2009, 35(2):171-180. [discussion: 81-2].
23. Kurhanewicz J., Vigneron D., Carroll P., et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 2008, 18(1):71-77.
24. Wang L., Akin O., Mazaheri Y., et al. Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?. BJU Int 2010, 106(9):1303-1308.
25. Nogueira L., Wang L., Fine S.W., et al. Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. Urology 2010, 75(2):472-477.
26. Westphalen A.C., McKenna D.A., Kurhanewicz J., et al. Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol 2008, 22(4):789-794.
27. McKenna D.A., Coakley F.V., Westphalen A.C., et al. Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy-initial experience. Radiology 2008, 247(1):141-146.
28. Wang L., Hricak H., Kattan M.W., et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 2006, 238(2):597-603.
29. Sala E., Eberhardt S.C., Akin O., et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006, 238(1):176-183.
30. Hricak H., Wang L., Wei D.C., et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004, 100(12):2655-2663.
31. Yu K.K., Scheidler J., Hricak H., et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999, 213(2):481-488.
32. Hricak H., White S., Vigneron D., et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994, 193(3):703-709.
33. Rosen M.A., Goldstone L., Lapin S., et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 1992, 148(2 Pt 1):331-337.
34. Zelhof B., Lowry M., Rodrigues G., et al. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions. BJU Int 2009, 104(5):621-627.
35. Wu L.M., Xu J.R., Ye Y.Q., et al. The clinical value of diffusion-weighted imaging in combination with t2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol 2012, 199(1):103-110.
36. Woodfield C.A., Tung G.A., Grand D.J., et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. Am J Roentgenol 2010, 194(4):W316-W322.
37. Hambrock T., Somford D.M., Huisman H.J., et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011, 259(2):453-461.
38. Verma S., Rajesh A., Morales H., et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011, 196(2):374-381.
39. Bittencourt L.K., Barentsz J.O., de Miranda L.C., et al. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol 2012, 22(2):468-475.
40. Westphalen A.C., Reed G.D., Vinh P.P., et al. Multiparametric 3T endorectal MRI after external beam radiation therapy for prostate cancer. J Magn Reson Imaging 2012, 36(2):430-437.
41. Jung J.A., Coakley F.V., Vigneron D.B., et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004, 233(3):701-708.
42. 3) spatial resolution. Radiology 1996, 198(3):795-805.
43. Kurhanewicz J., Swanson M.G., Nelson S.J., et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002, 16(4):451-463.
44. Westphalen A.C., Coakley F.V., Qayyum A., et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology 2008, 246(1):177-184.
45. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005, 234(3):804-814.
46. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006, 241(2):449-458.
47. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002, 223(1):91-97.
48. Westphalen A.C., Coakley F.V., Roach M., et al. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 2010, 256(2):485-492.
49. Weinreb J.C., Blume J.D., Coakley F.V., et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy-results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 2009, 251(1):122-133.
50. Shukla-Dave A., Hricak H., Akin O., et al. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 2012, 109(9):1315-1322.
51. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997, 7(1):91-101.
52. van Dorsten F.A., van der Graaf M., Engelbrecht M.R., et al. Combined quantitative dynamic contrast-enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004, 20(2):279-287.
53. Verma S., Turkbey B., Muradyan N., et al. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol 2012, 198(6):1277-1288.
54. Heijmink S.W., Fütterer J.J., Hambrock T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of Image quality, localization, and staging performance. Radiology 2007, 244(1):184-195.
55. Fütterer J.J., Engelbrecht M.R., Jager G.J., et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Eur Radiol 2007, 17(4):1055-1065.
56. Kurhanewicz J., Vigneron D.B., Nelson S.J. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2000, 2(1-2):166-189.